| Example
of a Typical Pricing Authority Meeting
PHARMACEUTICAL BENEFITS
PRICING AUTHORITY
MEETING - 18
APRIL 2001 - 10.00 AM
AGENDA
- MINUTES OF PREVIOUS MEETING AND ADMINISTRATIVE
MATTERS
- Draft minutes of previous meeting of 11 January 2001
- Industry and consumer matters for discussion
- THERAPEUTIC RELATIVITIES
- LIAISON WITH PBAC
- Results of price negotiations from PBAC meeting of December 2000
- Outcomes of PBAC meeting of March 2001
- PBAC Financial Implications (March PBAC) and items referred to
PBAC from the Pricing Authority
- REVIEW OF ATC GROUPS (Please see below for
review dates of all groups)
ATC
Code GROUP
G GENITO URINARY SYSTEM & SEX HORMONES
GO1 Gynecological and Antiinfectives & Antiseptics
GO2 Other Gynecologicals
GO3 Sex Hormones and Modulators of the Genital System
GO4 Urologicals
H SYSTEMIC HORMONAL PREPARATIONS, EXCLUDING
SEX HORMONES
HO1 Pituitary, Hypothalamic Hormones and Analogues
HO2 Corticosteroids for Systematic Use
HO3 Thyroid Therapy
H04 Pancreatic Hormones
HO5 Calcium Homeostasis
J GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
JO1 Antibacterials for Systematic Use
JO2 Antimycotics for Systematic Use
JO4 Antimycobacterials
JO5 Antivirals for Systematic Use
JO6 Immune Sera and Immunoblobulins
JO7 Vaccines
- AD-HOC ITEMS
NOTE CUT-OFF DATE FOR SUBMISSIONS 21 MARCH
2001
Top of Page
PHARMACEUTICAL
BENEFITS PRICING AUTHORITY
11 JULY 2001 MEETING
ATC GROUPS
ATC
Code GROUP
D DERMATOLOGICALS
D01 Antifungals for Dermatological Use
D02 Emollients and Protectives
D05 Antipsoriatics
D06 Antibiotics and Chemotherapeutics for Dermatological Use
D07 Corticosteroids, Dermatological Preparations
D08 Antiseptics and Disinfectants
D10 Anti-Acne Preparations
M MUSCULOSKELETAL SYSTEM
M01 Antiinflammatory and Antirheumatic Products
M02 Topical Products for Joint and Muscular Pain
M03 Muscle Relaxants
M04 Antigout Preparations
M05 Drugs for Treatment of Bone Diseases
M09 Other Drugs for Disorders of the Musculo-Skeletal System
N NERVOUS SYSTEM
N02 Analgesics
N03 Antiepileptics
N04 Anti-Parkinson drugs
N05 Psycholeptics
N06 Psychoanaleptics
N07 Other Nervous System Drugs
P ANTIPARASITIC PRODUCTS, INSECTICIDES
AND REPELLANTS
P01 Antiprotozoals
P02 Anthelmintics
P03 Ectoparasiticides, including Scabicides,
Insecticides and Repellants
Section 100 Items
NOTE CUT-OFF DATE FOR SUBMISSIONS 13 JUNE 2001
Top of Page
PHARMACEUTICAL BENEFITS
PRICING AUTHORITY
10 OCTOBER 2001 MEETING
ATC GROUPS
ATC
Code GROUP
A ALIMENTARY TRACT AND METABOLISM
A01 Stomatological Preparations
A02 Antacids, Drugs for Treatment of Peptic Ulcer and Flatulence
A03 Antispasmodic and Anticholinergic Agents and Propulsives
A04 Antiemetics and Antinauseants
A06 Laxatives
A07 Antidiarrheals, Intestinal Antiinflammatory/Antiinfective Agents
A09 Digestives, including Enzymes
A10 Drugs used in Diabetes
A11 Vitamins
A12 Mineral Supplements
A14 Anabolic Agents for Systemic use
S SENSORY ORGANS
S01 Ophthalmologicals
S02 Otologicals
S03 Ophthalmological and Otological Preparations
V VARIOUS
V01 Allergens
V03 All Other Therapeutic Products
V04 Diagnostic Agents
V06 General Nutrients
V07 All Other Non-Therapeutic Products
NOTE CUT-OFF DATE FOR SUBMISSIONS 12 SEPTEMBER
2001
Top of Page
PHARMACEUTICAL BENEFITS
PRICING AUTHORITY
9 JANUARY 2002 MEETING
ATC GROUPS
ATC
Code GROUP
B BLOOD & BLOOD FORMING ORGANS
B01 Antithrombotic Agents
B02 Antihemorrhagics
B03 Antianemic Preparations
B05 Plasma Substitutes and Perfusion Solutions
C CARDIOVASCULAR SYSTEM
C01 Cardiac Therapy
C02 Antihypertensives
C03 Diuretics
C04 Peripheral Vasodilators
C07 Beta Blocking Agents
C08 Calcium Channel Blockers
C09 Agents Acting on the Renin-Angiotensin System
C10 Serum Lipid Reducing Agents
L ANTINEOPLASTICS & IMMUNOMODULATING
AGENTS
L01 Antineoplastic Agents
L02 Endocrine Therapy
L03 Immunomodulating Agents
L04 Immunosuppressive Agents
R RESPIRATORY SYSTEM
R01 Nasal Preparations
R03 Anti-Asthmatics
R05 Cough and Cold Preparations
R06 Antihistamines for Systemic Use
NOTE CUT-OFF DATE FOR SUBMISSIONS 12 DECEMBER
2001
Top of Page
|